Heavis (Cytisinicline)

Heavis is indicated as an aid to quit smoking in adults who are motivated to stop using tobacco.

• Reducing nicotine cravings during a quit attempt.
• Alleviating withdrawal symptoms such as irritability and anxiety.
• Supporting behavioral counseling or cessation programs.
• May be used as part of a step‑down regimen after initial therapy.
• Facilitating transition to nicotine‑free status by moderating receptor activity.
• Providing a pharmacologic option when nicotine replacement therapy is unsuitable.
• The medication is taken orally and is prescribed by healthcare professionals as part of a comprehensive cessation plan.

Side effects reported with Heavis vary in frequency and severity.

Common

• Nausea or upset stomach, often mild and transient.
• Headache, which may improve with continued use.
• Insomnia or disturbed sleep patterns, especially during the first weeks.
• Dry mouth, sometimes accompanied by mild throat irritation.
• Dizziness, generally brief and resolves without intervention.
• Fatigue or feeling of low energy, usually diminishing over time.

Serious

• Severe allergic reaction, such as rash, swelling, or difficulty breathing, requiring immediate medical attention.
• Mood changes including depression, anxiety, or thoughts of self‑harm, which should be reported promptly.
• Cardiovascular events like rapid heart rate, palpitations, or chest discomfort that may need evaluation.

Precautions for Heavis focus on patient selection, medical history, and monitoring during therapy.

• Assess cardiovascular health before initiating therapy.
• Evaluate for history of psychiatric disorders, including depression or anxiety.
• Use caution in patients with hepatic or renal impairment; dose adjustment may be needed.
• Advise patients to avoid abrupt discontinuation without medical guidance.
• Counsel pregnant or breastfeeding women that safety has not been established.
• Monitor for signs of allergic reaction during the first weeks of treatment.
• Review all concomitant medications to reduce interaction risk.

Heavis may interact with other medicines; some combinations should be avoided while others require careful monitoring.

Avoid

• Concurrent use with monoamine oxidase inhibitors (MAOIs) due to potential hypertensive reactions.
• Combining with other nicotinic receptor agonists or partial agonists, which could increase adverse effects.

Use with caution

• Co‑administration with antidepressants, especially SSRIs or SNRIs, may affect mood monitoring.
• Use with antihypertensive drugs may require blood pressure observation.
• Concurrent use of CYP450‑metabolized drugs, as cytisinicline metabolism pathways are not fully defined.
• Over‑the‑counter cough suppressants containing dextromethorphan should be used cautiously.